Main characteristics of the 520 cases of asthma identified in the GEIRD study.

<p>Main characteristics of the 520 cases of asthma identified in the GEIRD study.</p

Association between the Symptom frequency and anti-asthmatic Treatment intensity Score (STS) at baseline (1991–1993) and long-term outcomes at the end of follow-up (1999–2001).

<p>Data from the ECRHS study.</p

Coding and definition of the candidate variables.

<p>Coding and definition of the candidate variables.</p

Main characteristics of the 520 cases of asthma identified in the GEIRD study.

<p>Main characteristics of the 520 cases of asthma identified in the GEIRD study.</p

Distribution of the Symptom frequency and anti-asthmatic Treatment intensity Score (STS).

<p>Data from the GEIRD study.</p

Median of the Symptom frequency and anti-asthmatic Treatment intensity Score (STS) according to the GINA classification of asthma severity.

<p>Data from the GEIRD study.</p

Flow chart of the GEIRD study in the Pavia, Sassari, Turin and Verona centres, and selection of the cases of asthma.

<p>Flow chart of the GEIRD study in the Pavia, Sassari, Turin and Verona centres, and selection of the cases of asthma.</p

Relationship between the Symptom frequency and anti-asthmatic Treatment intensity Score (STS) computed by using the weights from the GEIRD data (horizontal axis) and STS computed by using the weights from the ECRHS II data (vertical axis).

<p>Relationship between the Symptom frequency and anti-asthmatic Treatment intensity Score (STS) computed by using the weights from the GEIRD data (horizontal axis) and STS computed by using the weights from the ECRHS II data (vertical axis).</p

Fuse: Accurate Multiplexing of Hardware Performance Counters Across Executions

*<p>Also adjusted for the type of interview (telephone vs face to face).</p><p>£ Overall adjusted p-value for smoking  = 0.5896.</p>§<p>IQR, Interquartile Range: (1^st quartile–3^rd quartile).</p>‡<p>Overall adjusted p-value for asthma control at baseline <0.0001.</p><p>Significant unadjusted p-value and adjusted OR (p<0.05) are reported in bold.</p

Distribution of GINA-based asthma control at follow-up according to GINA-based asthma control measured at baseline.

<p>The percentage of subjects in each category of GINA-based asthma control at follow up is reported inside histograms. The numbers of subjects with controlled, partially controlled and uncontrolled asthma at baseline are different from those reported in the result section due to missing data on control at follow-up.</p